Axovant has just one drug candidate, a 29-year old CEO — and a market cap of nearly $3 billion. Related posts: South Africa’s Zuma says has confidence in finance minister Gordhan UPDATE 1-Australia’s central bank bucks global easing trend, holds rates U.S. military flags concerns on CP, Norfolk Southern voting trust Swedish krona rises after Riksbank expands QE; dollar buys 8.0770 Post navigation Sharp losses push WTI below $60 a barrel, amid continuing rig decline July oil down 81 cents on day to settle at $59.96/bbl on Nymex